BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17433972)

  • 1. A small proportion of glioblastoma patients are probably eligible for concomitant/adjuvant temozolomide.
    O'Toole L; Khanduri S; Gerrard GE
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):269. PubMed ID: 17433972
    [No Abstract]   [Full Text] [Related]  

  • 2. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

  • 3. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
    Abrey LE
    Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant temozolomide: how long and how much?
    Franceschi E; Tosoni A; Brandes AA
    Expert Rev Anticancer Ther; 2008 May; 8(5):663-5. PubMed ID: 18471038
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
    Rivoirard R; Falk AT; Chargari C; Guy JB; Mery B; Nuti C; Peoc'h M; Forest F; Garin C; Adjabi A; Hoarau D; Kawaye S; Almokhles H; Fournel P; Magné N
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):486-7. PubMed ID: 25963856
    [No Abstract]   [Full Text] [Related]  

  • 6. Temozolomide (Temodar).
    Wesolowski JR; Rajdev P; Mukherji SK
    AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taming a mutinous mutant: an errant receptor becomes a prime cancer target.
    Goldman B
    J Natl Cancer Inst; 2007 Apr; 99(7):504-5. PubMed ID: 17405993
    [No Abstract]   [Full Text] [Related]  

  • 8. Temozolomide. A new option for high-grade astrocytomas.
    Schwenka J; Ignoffo RJ
    Cancer Pract; 2000; 8(6):311-3. PubMed ID: 11898150
    [No Abstract]   [Full Text] [Related]  

  • 9. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we afford to add chemotherapy to radiotherapy for glioblastoma multiforme? Cost-identification analysis of concomitant and adjuvant treatment with temozolomide until patient death.
    Wasserfallen JB; Ostermann S; Pica A; Mirimanoff RO; Leyvraz S; Villemure JG; Stupp R
    Cancer; 2004 Nov; 101(9):2098-105. PubMed ID: 15389472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More from PHARMAC on temozolomide: feedback needed.
    Rasiah D
    N Z Med J; 2006 Mar; 119(1230):U1896. PubMed ID: 16532057
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential usefulness of radiosensitizers in glioblastoma.
    Harasaki Y; Waziri A
    Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elderly patients with glioblastoma: the treatment challenge.
    Fiorentino A; De Bonis P; Chiesa S; Balducci M; Fusco V
    Expert Rev Neurother; 2013 Oct; 13(10):1099-105. PubMed ID: 24117272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Going past the data for temozolomide.
    Villano JL; Letarte N; Bressler LR
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):1113-5. PubMed ID: 22147076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
    Zheludkova OG; Tarasova IS; Gorbatykh SV; Belogurova MB; Kumirova EV; Borodina ID; Prityko AG; Melikian AG; Shcherbenko OI
    Vopr Onkol; 2002; 48(3):356-60. PubMed ID: 12455362
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme.
    De Sanctis V; Mazzarella G; Osti MF; Valeriani M; Alfó M; Salvati M; Banelli E; Tombolini V; Enrici RM
    Anticancer Drugs; 2006 Sep; 17(8):969-75. PubMed ID: 16940807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor.
    Bracht LK; Wen P; Meyerhardt JA; Kulke MH; Hornick JL; Redston M; LaFrankie DC; Black PM; Kesari S; Norden A; Drappatz J
    J Clin Oncol; 2008 Oct; 26(29):4843-4. PubMed ID: 18779600
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma - three case reports - .
    Sakamoto N; Ishikawa E; Yamamoto T; Satomi K; Nakai K; Sato M; Enomoto T; Morishita Y; Takano S; Ohno T; Tsuboi K; Matsumura A
    Neurol Med Chir (Tokyo); 2011; 51(4):319-25. PubMed ID: 21515959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 20. PHARMAC's response on temozolomide and funding costly medicines that prolong life shortly.
    Metcalfe S; Crausaz S; Moodie P; McNee W
    N Z Med J; 2005 Dec; 118(1227):U1806. PubMed ID: 16372042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.